Sleep Disorders Medicine In Psychiatry. Alan B. Douglass MD, FRCPC, Dip. ABPN, Dip. Amer. Board of Sleep Medicine Asst. Professor, Dept of Psychiatry, University of Ottawa Medical Director, Sleep Disorders Service, Royal Ottawa Hospital. Introduction.
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation
Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement.Téléchargez la présentation en cliquant sur ce lien.Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.
F I N
Plus de contenu associé
Transcription de la présentation
Sleep Disorders MedicineIn Psychiatry Alan B. Douglass MD, FRCPC, Dip. ABPN, Dip. Amer. Board of Sleep Medicine Asst. Professor, Dept of Psychiatry, University of Ottawa Medical Director, Sleep Disorders Service, Royal Ottawa Hospital
Introduction • Financial Disclosure: Nothing to declare • Today we will cover: • Basic sleep physiology • Narcolepsy – a disorder of the REM control system • Periodic Limb Movement Disorder • Obstructive Sleep Apnea • Insomnia – diagnosis & treatment
Narcolepsy Treatments: • SLEEPINESS: • Stimulants (noradrenalin receptor agonists): amphetamine, methylphenidate, modafinil. • CATPLEXY: • Antidepressants that increase serotonin and or noradrenaline and block ACh, i.e. clomipramine, venlafaxine.
Narcolepsy versus Schizophrenia Apparent “Schizophrenic” Hallucinations Actually Daytime REM sleep intrusion Narcolepsy • 90% aassociation of narcolepsy with an HLA antigen DNA fragment (DQB1*0602) allows “inverse” screening of schizophrenics for narcolepsy • Narcolepsy is detectable in sleep lab (MSLT) but pt. must be medication-free for at least 3 weeks.
Clinical Applicability – Apnea • Sleep apnea and depression share clinical features; apnea can produce secondary depression. • Serious sleep apnea can cause sufficient impairment to suggest dementia; severe snoring in a “demented” patient could be a treatable illness. • Apnea or PLMD can cause sleep deprivation which can cause relapse of mania or depression.
RLS – PLMD: neurochemistry • Likely due to iron deficiency in basal ganglia (Fe++ is co-factor for enzymes that synthesize DA). • May predict onset of “syn-nuclein-opathies” (REM behaviour disorder, PSP, Parkinson’s, Lewy Body dementia).
SYMPTOMS Late evening / night Legs cramp, squirm, move by themselves Multiple awakenings “Charley Horses” Can’t tolerate legs being immobilized Worse in elderly TREATMENT Check Fe, ferritin, B12, folate Dopamine agonists (L-DOPA, ropinirole, pramipexole) Benzodiazepines or opiates now 2nd line Quinine obsolete RLS – PLMD: Sx and Tx
Sleep Abnormalities in Psychiatry Benca, 1992 • Meta-analysis of sleep in all major psychiatric disorders showed affective disorders had the largest and most consistent differences from controls. Kaneko, 1981 • Extremely short nocturnal REM latency is common to both psychiatric disorders and narcolepsy
Psychiatric Sleep Measurements • Sleep Latency (SL) – sleep onset defined as first 3 contiguous 30-sec. pages of Stage 1 sleep • REM Latency (RL) – time from sleep onset to first epoch of REM sleep • REM Latency Minus Awake (RLMA) – subtract any interposed pages of waking from the RL • Eye Movement Density in REM Sleep(REM Density, RD) – the actual number of eye movements divided by minutes spent in REM
REM Latency (RL & RLMA) • RL varies inversely with age & is highly prevalent in affective disorders. • RLMA has statistical properties that are superior to RL (smaller variance, more normal distribution). • RL is shortened by cholinergic agonists (arecoline, pilocarpine, physostigmine). • Prolonged by anticholinergics (benztropine, trihexyphenidyl, diphenhydramine).
MDD: sleep features • Long initial insomnia, early morning wakening • Shallow sleep, easily awakened • Non-refreshing sleep • Short RL & RLMA; normalized by SSRI (antidepressants are REM suppressants because they increase neurotransmission in serotonergic and adrenergic pathways). • High REM density (also a good predictor of eventual depression in a never-ill person)
MDD (cont.) • Some powerful sleep mechanism underlies the expression of depression • Total sleep deprivation or selective REM deprivation dramatically improves mood of severely depressed patients (benefit is lost after one night’s sleep or even short nap) • Amount of Non-REM sleep in nap predicts worsening of mood
Bipolar Disorder vs. MDD • MDD patients typically have reduced total night sleep, but normal day alertness • Depressed bipolar patients in often have excess sleep (up to 18 hours/day), crushing fatigue when awake, ravenous appetite, & weight gain: “atypical depression”. • “Switch process” in bipolars often occurs during sleep.